10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $264,296 | +1.7% | 4,733 | +1.6% | 0.00% | – |
| Q1 2023 | $259,975 | -66.9% | 4,660 | -78.4% | 0.00% | -100.0% |
| Q4 2022 | $784,492 | +57.2% | 21,528 | +22.8% | 0.00% | 0.0% |
| Q3 2022 | $499,000 | -51.7% | 17,532 | -23.3% | 0.00% | -50.0% |
| Q2 2022 | $1,034,000 | -38.3% | 22,861 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $1,677,000 | -37.8% | 22,040 | +21.7% | 0.00% | -50.0% |
| Q4 2021 | $2,698,000 | +293.9% | 18,113 | +285.1% | 0.00% | +300.0% |
| Q3 2021 | $685,000 | -30.0% | 4,704 | -5.8% | 0.00% | 0.0% |
| Q2 2021 | $978,000 | -57.4% | 4,991 | -60.6% | 0.00% | -75.0% |
| Q1 2021 | $2,296,000 | +134.0% | 12,682 | +83.1% | 0.00% | +100.0% |
| Q4 2020 | $981,000 | +373.9% | 6,927 | +155.7% | 0.00% | – |
| Q4 2019 | $207,000 | – | 2,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |